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Accepted: January 2, 2003Abstract Numerous virulence factors such as O antigen
have been proposed to account for the fulminating and
destructive nature of V. vulnificus infections. To better
characterize the role of O antigen, a pmm gene encoding a
phosphomannomutase was identified and cloned from V.
vulnificus. The deduced amino acid sequence of the pmm was
42 to 71% similar to that reported from other Enterobacteriaceae.
Functions of the pmm gene in virulence were assessed by the
construction of an isogenic mutant, whose pmm gene was
inactivated by allelic exchanges, and by evaluating its phenotype
changes in vitro and in mice. The disruption of pmm resulted
in a loss of more than 90% of phosphomannomutase, and
reintroduction of recombinant pmm could complement the
decrease of phosphomannomutase activity, indicating that the
pmm gene encodes the phosphomannomutase of V. vulnificus.
There was no difference in the LD50s of the wild-type and the
pmm mutant in mice, but the LD50s observed by the mutant
complemented with recombinant pmm were lower. Therefore,
it appears that PMM is less important in the pathogenesis of V.
vulnificus than would have been predicted by examining the
effects of injecting purified LPS into animals, but it is not
completely dispensable for virulence in mice.
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The pathogenic marine bacterium Vibrio vulnificus is
the causative agent of food-borne diseases such as life-
threatening septicemia and possibly gastroenteritis in individuals
with underlying predisposing conditions such as liver damage,
excess levels of iron, and immunocompromised conditions
[2, 14, 15]. Wound infections result from exposure to
seawater or from the handling of shellfish contaminated
with V. vulnificus. Mortality from septicemia is very high
(>50%), and death may occur within one to two days after
the first signs of illness [2, 14].
The symptoms which occur with V. vulnificus septicemia,
as well as the inflamatory response observed in wound
infections, are those associated with the endotoxic activity
of lipopolysaccharide (LPS) molecules, rendering it a prime
candidate as a major virulence factor [21]. Very little is
known so far regarding the biosynthetic pathway for the
LPS of V. vulnificus, and its genes encoding enzymes
involved in the production of LPS have not yet been
identified. However, it is generally believed that a similar
biosynthetic pathway has been proposed to operate in
Gram-negative bacteria. The molecular genetics of LPS
production of Pseudomonas aeruginosa have been widely
studied [17]: The glycolytic intermediate fructose-6-phosphate
is first converted to mannose-6-phosphate by the action of
phosphomannose isomerase. Mannose-1-phosphate is then
formed by the action of phosphomannomutase (PMM) and
further converted to GDP-mannose, which is a common
metabolite used for the synthesis of different saccharides
of LPS [16].
The characteristics of V. vulnificus LPS as a potential
virulence factor have been studied primarily using the
purified LPS in animal models. In fact, McPherson et al.
[18] demonstrated that intravenous injections of V. vulnificus
LPS into mice caused mean arterial pressure to decrease
within 10 min, with a further decline and subsequent death
in 30 to 60 min. One of the leading factors believed to
contribute to fatality in Gram-negative septicemia is the
overproduction of tumor necrosis factor (TNF), leading to
overstimulation of nitric oxide synthase, in response to
LPS. In fact, increased mortality in cirrhotic mice due to V.
vulnificus infection is dependent on an in vivo TNF-α
response [6]. Purified V. vulnificus LPS causes severe
hypotension and death within 1 h, when injected into rats
[5]. However, when a nitric oxide synthase inhibitor
is administered to rats along with LPS, the lethality of
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150 LEE et al.the endotoxin is reversed [18]. These data suggest that
the stimulation of TNF, followed by nitric oxide (NO)
production, leads to endotoxic shock in response to V.
vulnificus LPS.
However, in contrast to the reported effects of
administrating V. vulnificus LPS in experimental animals, a
definitive analysis of the role of the V. vulnificus LPS by
the construction of a defined mutation has not yet been
reported. We therefore undertook this study to identify the
function of the LPS during an infectious process, rather
than the artificial system of injecting purified LPS, by
constructing the isogenic PMM mutant of V. vulnificus and
applying the molecular version of Koch’s postulates [7].
The bacterial strains and plasmids used in this study are
listed in Table 1. E. coli strains used for plasmid DNA
replication or conjugational transfer of plasmids were grown
in Luria-Bertani (LB) broth or on LB broth containing
1.5% (w/v) agar. Unless otherwise noted, V. vulnificus strains
were grown in LB medium supplemented with 2.0% (w/v)
NaCl (LBS). Cultures of V. vulnificus strains were grown
at 30oC with aeration. Five ml samples were removed at
log phase for determination of cell densities, PMM activities,
and cellular protein concentrations. The PMM activities
were determined according to the method of Goldberg et
al. [9]. One unit of the enzyme activity was defined as the
amount of enzyme needed to reduce 1 µmol of NADP to
NADPH per min, as described previously [26]. Protein
concentrations were determined by the method of Bradford
[3], with bovine serum albumin as the standard. Averages
and standard errors of the mean (SEM) were calculated
from at least three independent determinations.
Cloning and Sequence Analysis of the pmm Gene
Recent reports suggest that environmental cues, such as
cell density, may govern virulence gene expression in
many Gram-negative bacteria [19]. It has been recognized
that bacteria can regulate gene expression in response
to cell density, and quorum-sensing systems based on
acylhomoserine lactone autoinducer (AI-1) molecules are
widespread among Gram-negative bacteria [8]. Recently,
an alternative, highly conserved quorum-sensing system used
by both Gram-positive and Gram-negative bacteria has
been identified [1]. This system requires a highly conserved
locus, luxS. It has been proposed that LuxS acts on
a metabolic intermediate to synthesize a unique signaling
molecule, termed autoinducer 2 (AI-2). However, until now,
no study addressed the genes whose expression is regulated
by the AI-2 quorum sensing system in V. vulnificus.
Therefore, as an effort to identify genes that are regulated by
the AI-2 quorum-sensing system, we cloned genes differentially
Table 1. Plasmids and bacterial strains used in this study.
Strain or plasmid Relevant characteristicsa Reference or source
Bacterial strains
V. vulnificus
ATCC29307 Clinical isolate; virulent Laboratory collection
HS01 ATCC29307 with luxS::nptI; Aps, Kmr This study
JH001 ATCC29307 with pmm::nptI; Aps, Kmr This study
E. coli
DH5α supE44 ∆ lacU169 (φ80 lacz ∆M15) hsdR17 recA1 endA1 gyrA96 thi-1 relAI Laboratory collection
SY327 λ pir ∆(lac pro) argE(Am) recA56 gyrA rpoB λpir; host for
pi-requiring plasmids; conjugal donor [20]
SM10 λ pir thi thr leu tonA lacY supE recA::RP4-2-Tc::Mu λpir; Kmr;
host for pi-requiring plasmids; conjugal donor [20]
Plasmids
pGEM-T Easy PCR product cloning vector; Apr Promega 
pUC18 Cloning vector; Apr Laboratory collection
pBR322 Cloning vector; Apr, Trr Laboratory collection
pUC4K pUC4 with nptI; Apr, Kmr [22]
pCVD442 R6K γ ori; sacB; Suicide vector; oriT of RP4; Apr [4]
pRK415 IncP ori; broad-host-range vector; oriT of RP4; Tcr [12]
pKC600 494-bp PCR product containing pmm cloned into pGEM-T Easy vector; Apr This study
pJH0020 Cosmid library containing pmm; Tcr This study
pJH0021 7.0-kb PstI fragment containing pmm cloned into pUC18; Apr This study
pJH0027 pBR322 with pmm, Apr, Trs This study
pJH0028 pJH0027 with pmm::nptI; Apr, Kmr This study
pJH0029 pCVD442 with pmm::nptI; Apr, Kmr This study
pJH0030 pRK415 with pmm; Tcr This study
a: Apr, ampicillin resistant; Kmr, kanamycin resistant; Tcr, tetracycline resistant; Tcs, tetracycline sensitive.
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display) PCR [25]. The luxS mutant was constructed by
allelic exchange in ATCC29307 (Choi, 2002, unpublished
data). Cultures of ATCC29307 and the luxS mutant were
grown to log phase, and total cellular RNAs were isolated
using a Trizol reagent kit according to the manufacturer’s
specifications (GIBCO-BRL, Gaithersburg, MD, U.S.A.). For
reverse transcriptase (RT) PCR of the genes differentially
expressed in luxS mutant, total RNA was reverse transcribed
essentially following the manufacturer’s (GIBCO-BRL)
protocol in a total volume of 20 ml reaction mixture. For
PCR amplification, each 2 µl sample of the resulting cDNA
was used as a template, and OPA4 (5'-AATCGGGCTG-3')
as a random primer.
The resulting PCR product, a 494-bp DNA fragment,
was purified from the agarose gels and cloned into the
pGEM-T Easy vector (Promega, Madison, WI, U.S.A.)
according to the manufacturer’s specifications, yielding
plasmid pKC600. Since the deduced amino acid sequence
of the resulting PCR product revealed 79% identity with
that of V. cholerae pmm, the DNA was labeled with [α-
32P]dCTP and named PmmP. To clone the full gene of the
pmm, a cosmid library of V. vulnificus ATCC29307,
constructed using pLAFR3 [13, 24], was screened using
PmmP as a probe. A colony showing a positive signal was
isolated, and the cosmid DNA was purified and named
pJH0020 (Fig. 1). A 7.0-kb band from the cosmid DNA
digested with PstI was purified and ligated into pUC18 to
result in pJH0021, as shown in Fig. 1.
The nucleotide sequences of the DNA fragments in
pJH0021 were determined by primer walking (Korea Basic
Science Research Center, Kwang-Ju, Korea), and the
sequence data were submitted to the GenBank [Accession
number AY205154]. The nucleotide sequence revealed a
coding region consisting of 1,707 nucleotides (Fig. 1). The
pmm from V. cholerae was 61% identical in nucleotide
sequences with the coding region in pJH0021 (data not
shown). This information proposed that the coding region
is a homolog of the pmm gene from V. cholerae and led us
to name the coding region pmm of V. vulnificus. The amino
acid sequence deduced from the pmm nucleotide sequence
revealed
 
a protein, a PMM composed of 568 amino acids
with a theoretical molecular mass of 62,582 Da and a PI of
5.67. A database search for amino acid sequences similar
to those deduced from the pmm coding region revealed
three other PMM proteins from V. cholerae, Shewanella
oneidensis, and Pasteurella multocida strains with high
levels of identity (Fig. 2, http//www.ncbi.nml.nih.gov).
The amino acid sequence of the V. vulnificus PMM was
71% identical to that of the PMM of V. cholerae, and their
identity appears evenly throughout the whole proteins
(data not shown). All of this information confirmed that
the pmm gene encodes the PMM of V. vulnificus.
Generation and Confirmation of the pmm::nptI Mutant
The pmm gene in pJH0027 (Table 1) that was constructed
by ligation of a 1.7-kb BamHI-HindIII fragment of pJH0021
with pBR322 was inactivated in vitro by insertion of nptI
encoding for aminoglycoside 3'-phosphotransferase and
conferring resistance to kanamycin [22]. The 1.2-kb DNA
fragment carrying nptI was isolated from pUC4K (Pharmacia,
Piscataway, NJ, U.S.A.) and inserted into a unique NsiI site
present within the open reading frame (ORF) of pmm. The
2.9-kb pmm::nptI cartridge from the resulting construct
Fig. 1. Physical map of the V. vulnificus pmm gene on the plasmids used in this study.
(A) Plasmid pJH0021 was used to determine the nucleotide sequence of pmm. The shaded boxes represent the locations of one complete open reading frame
(pmm) and partial open reading frame (alzC) and directions of their transcription. (B) Depicted is the region cloned in the plasmid used for construction of
pmm::nptI mutant. The insertion position of nptI cassette is indicated by the open triangle. Abbreviations; P, PstI; B, BamHI; H, HindIII.
Fig. 2. Amino acid-sequence relatedness of PMMs of V.
vulnificus and other bacteria.
Dendrogram showing relatedness of PMM was derived using the DNASIS
alignment program (version 2.6, Hitachi Software Engineering Co., Ltd.,
Japan), and based on the amino acid sequences in the GenBank databases
(NCBI).
152 LEE et al.(pJH0028, Fig. 2B) was liberated and ligated with SmaI-
digested pCVD442 [4], forming pJH0029 (Table 1).
E. coli SM10pir (containing pJH0029) was used as a
conjugal donor to generate the pmm::nptI mutant of V.
vulnificus ATCC29307 by homologous recombination (Fig.
3A). The V. vulnificus pmm mutant chosen for further
analysis was named JH001. The conjugation and isolation
of the transconjugants were conducted using the methods
previously described [10], and a double crossover, in which
each wild-type pmm gene was replaced with the pmm::nptI
allele, was confirmed by PCR as shown in Figure 3B. PCR
analysis of genomic DNA from ATCC29307 with primers
PMM002 (5'-GTACTGCAGTTTAGAGAAAACAGAG-
AGAGTAAG-3') and PMM003 (5'-TTAGAATTCAAG-
AGCACACTCATACGTCGAGTG-3') produced a 1.7-kb
fragment (Fig. 3B), whereas genomic DNA from the JH001
resulted in an amplified DNA fragment, approximately 2.9-
kb in length. The 2.9-kb fragment is in agreement with the
projected size of the DNA fragment containing wild-type
pmm (1.7-kb) and the nptI gene (1.2-kb). The inserted nptI
DNAs were stably maintained in the mutant, as determined
by maintenance of kanamycin resistance (all of more than
500 colonies tested) and by generation of the appropriate-
sized DNA fragment by PCR (data not shown).
Effects of Mutation in pmm Gene on Phosphomannomutase
Activity
For ATCC29307, PMM was produced and reached a
maximum 45.0 units (Fig. 4). The disruption of pmm in the
mutant JH001 resulted in reduced production of PMM
activity (p<0.05). The residual level of PMM activity in
JH001 corresponded to approximately one-tenth of that in
the wild-type. These data demonstrated that the pmm gene
encoded the PMM of V. vulnificus. However, the PMM
activity in JH001 was still evident and its level was significantly
higher than the background level observed, when control
assay was carried out in the absence of mannose. This
observation that the mutant still exhibited PMM activity
indicated the existence of at least one more PMM (or its
homolog) being produced by V. vulnificus ATCC29307.
To rule out the possibility that the decrease of PMM activity
by more than 90% resulted from polar effects of the pmm
Fig. 3. Allelic exchange procedure and construction of pmm::nptI isogenic mutant.
(A) Double homologous recombinations between strain ATCC29307 and plasmid pJH0029 led to interruption of pmm gene and resulted in construction of
the mutant JH001. Dashed lines represent the bacterial chromosome; a full line, the plasmid DNA; open box, the target pmm gene; shaded box, the nptI gene;
large X’s represent genetic crossing over. Abbreviations; SacB, levansucrase gene; bla, β-lactamase gene. (B) PCR analysis of ATCC29307 and isogenic
mutant generated by allelic exchange. Molecular size markers (1 kb plus DNA ladder, GIBCO-BRL) and PCR products are indicated.
Fig. 4. PMM activities of ATCC29307 and isogenic pmm
mutant.
Complementation of mutant with functional pmm (pJH0030) was also
presented as indicated. Error bars represent the S.E.M., WT, wild-type.
CLONING OF V. VULNIFICUS PMM 153insertional mutation on downstream genes, we examined
if reintroduction in pJH0030 carrying the recombinant
pmm could complement the decrease of PMM activity of
JH001 cells.
 
For this purpose, pJH0030 was constructed
by subcloning the pmm amplified by PCR using primers
PMM002 and PMM003 and then digested with PstI and
EcoRI into the broad host-range vector pRK415 [12]
linearized with the same enzymes. The resulting plasmid
was mobilized into V. vulnificus by conjugation. The PMM
activity of the JH001(pJH0030) was restored to a level
comparable to, even higher than, the wild-type level of
ATCC29307 (Fig. 4). Therefore, the decreased PMM activity
of JH001 resulted from inactivation of functional pmm rather
than any polar effects on any genes downstream of pmm.
Effects of pmm Mutation on the Virulence of V.
vulnificus
We examined the virulence of V. vulnificus ATCC29307
and JH001, using both iron dextran-treated and normal
ICR mice (Specific Pathogen-Free; Daehan Animal Co,
Taejon, Korea), as described [11]. Briefly, female mice
from 7 to 11 weeks of age were housed under specific
pathogen-free conditions. For the determination of LD50,
bacteria grown in BHI-N [11] broth overnight at 25oC were
harvested and suspended in PBS to appropriate concentrations,
ranging from 101 to 107 CFU in 10-fold increments. Group
of (n=6) 7-weeks-old normal female mice were injected
subcutaneously with 0.1 ml of serial dilutions of bacterial
suspensions. The infected mice were observed for 24 h,
and the LD50 were calculated by the method of Reed and
Muench [23]. For experiments involving iron treatment,
mice were injected intraperitoneally with 250 µg of iron
dextran per g of body weight immediately before injection
with bacterial cells.
As shown in Table 2, there was no difference in the
LD50s of ATCC29307 and JH001 in normal mice (none-
iron-treated), which were as high as 104 CFU for both
strains. In iron dextran-treated mice, the LD50s observed
by both strains were also indistinguishable (Table 2).
Therefore, in the mouse model of subcutaneous infection,
in which LD50s were compared with wild-type and pmm
mutant strains, the PMM appeared to be not important for
disease. However, it is notable that LD50s observed by
JH001(pJH0030) were lower in both normal mice and iron
dextran-treated mice. Taking these results together, it is
reasonable to assume that the PMM is not completely
dispensable for virulence in mice; however, we cannot
make any conclusions as to the role of PMM in general.
The major problem to be addressed is the difference in
virulence between the wild-type and the JH001 complemented
with pJH0030. Although other explanations are possible,
this discrepancy could be related to the level of PMM
expressed in the cells during infection. Complementation
with pJH0030 would provide JH001 with pmm, which is
expressed under the Plac promoter of pRK415 [12]. Therefore,
it might be possible that the number of PMM molecules
in the complemented cells could be relatively higher than
that in wild-type cells, in which all PMM molecules are
products of pmm, which is expressed by its own promoter
carried on the chromosome. This possibility strongly
underscores the necessity of understanding the regulation
of pmm expression. However, no promoter(s) of the pmm
gene has been identified, and the molecular mechanisms
by which the bacterium modulates the expression of the
pmm gene have not yet been characterized. This lack of
information on the regulatory characteristics of the pmm
gene makes it difficult to understand how the expression
pattern and level of PMM varies spatially and temporally
during infection with viable V. vulnificus.
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